ESTRO 2025 - Abstract Book

S143

Invited Speaker

ESTRO 2025

that for groups like ours organic growth and a healthy portion of bottom-up management is often the key to success. Jointly defined aims and healthy cooperation inside and outside these groups make the circle round so that in the end all these groups and subgroups can jointly generate the values, in which we all are interested, together. In the very end it sums up to creating joint value in terms of offering the best radiation treatments and thereby increasing the health of patients with cancer. I am forever grateful that I had the chance to contribute to creating such values, together.

4904

Speaker Abstracts Transforming radiotherapy by empowerment of RTTs Sophie Perryck Radiation Oncology, University Hospital Zurich, Zurich, Switzerland

Abstract:

Empowerment means to create a psychological safe environment in which trust is a main pillar. Employee confidence is built with recognition and offers flexibility for the department. It means asking employees for feedback and acting on it as well as supporting professional development. In a radiation oncology field this can be uses for efficiency purposes, a well build self-sufficient team of radiation therapists can relieve other professionals of their duties. Medical physicist and medical doctors are called in for tasks that aren’t standardized. With the correct training program and set of protocols every profession can be empowered.

4905

Speaker Abstracts Transforming radiotherapy by integrated local and systemic therapy George Rodrigues Radiation Oncology, London Health Sciences Centre, London, Canada

Abstract:

Radiation therapy has been successfully utilized in many tumor systems to achieve various clinical goals such as local, regional, and symptom control. Within the specialty of radiation oncology, significant improvements in radiation dose fractionation, target delineation, radiotherapy planning and delivery have improved the therapeutic ratio in cancer treatment. Similarly, systemic therapies have undergone a transformation over the past few decades with improvements in chemotherapy and the development of hormonal therapies, targeted biological therapy as well as immunotherapeutic approaches. Integration of these systemic therapies into radiotherapy protocols have improved results in multiple tumor systems over the past 50 years and form the bedrock of modern clinical oncological practice. Various approaches have been employed to integrate systemic therapy into radiotherapy treatments. Initially due to toxicity concerns, many initial protocols utilized either the neoadjuvant and/or adjuvant approaches. Concurrent delivery of systemic therapy and radiation have become routine in most non-metastatic solid tumour treatments. Recently, the use of targeted therapy and/or immunotherapy have revolutionized many cancer treatment protocols. Research into the integration of radiotherapy into these newer systemic therapy paradigms is an area of intense investigation. New concepts such as oligo-progression have provided new indications for the use of radiotherapy outside the traditional loco-regional control and palliative goals of therapy.